US Stock MarketDetailed Quotes

OVID Ovid Therapeutics

Watchlist
  • 0.466
  • +0.032+7.42%
Close Mar 17 16:00 ET
  • 0.489
  • +0.023+4.91%
Pre 08:00 ET
33.13MMarket Cap-1.26P/E (TTM)

About Ovid Therapeutics Company

Ovid Therapeutics, Inc. is a biopharmaceutical company, which engages in the development of medicines for patients and families living with rare neurological disorders. The company was founded by Matthew During in April 2014 and is headquartered in New York, NY.

Company Profile

SymbolOVID
Company NameOvid Therapeutics
Listing DateMay 5, 2017
Issue Price15.00
Founded2014
CEOMr. Jeremy M. Levin, D.Phil.,M.B.
MarketNASDAQ
Employees23
Fiscal Year Ends12-31
Address441 9th Avenue,14th floor
CityNew York
ProvinceNew York
CountryUnited States of America
Zip Code10001
Phone1-646-661-7661
Websitehttp://www.ovidrx.com

Company Executives

  • Name
  • Position
  • Salary
  • Jeremy M. Levin, D.Phil.,M.B.
  • Chairman of the Board and Chief Executive Officer
  • 2.14M
  • Jeffrey A. Rona
  • Principal Accounting Officer, Chief Business Officer and Chief Financial Officer
  • 1.08M
  • Margaret Alexander
  • Chief Operating Officer and President
  • --
  • Dr. Stelios Papadopoulos,PhD
  • Director
  • --
  • Dr. Kevin Fitzgerald, PhD
  • Independent Director
  • 71.66K
  • Barbara G. Duncan
  • Independent Director
  • 86.66K
  • Bart Friedman, J.D.
  • Independent Director
  • 104.16K
  • Dr. Karen Bernstein, PhD
  • Independent Director
  • 91.66K
  • Dr. Robert Michael Poole, F.A.C.P.,M.D.
  • Independent Director
  • 79.16K

Trending Stocks

Top Gaining Chinese Stocks Top Gaining Chinese Stocks
No. Symbol % Chg
Guangdong Hongjing Optoelectronic Technology Inc.
301479
+282.03%
LTECH
832110
+29.99%
FZFM
920082
+24.29%
4
JiangSu Jinji Industrial
300798
+20.05%
5
Shandong Nanshan Fashion Sci-Tech
300918
+20.02%
Log In for the Full List
Unlock Now
Investment Course
Top 5 Industries for Stock Trading under Trump's Second Term
Stocks & Industries to Watch Under Trump's Second Presidency
With mooomoo, find out which stocks and industries may benefit from Trump's second presidency, based on his first administration's track record.
Reassessing Chinese Assets
Following the introduction of China's groundbreaking DeepSeek technology, Wall Street giants have revised their investment outlooks for the Chinese market.
Discussing
Big Tech’s earnings season in full swing! Nvidia is the only one left
On Thursday, $Amazon (AMZN.US)$ stock fell after the firm reported Q4 adjusted earnings of $1.86/share, vs estimates of $1.50/share, on reve Show More
AMZN earnings preview: Grab rewards by guessing the opening price!